Immune Checkpoint Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
LIXT	B	Lixte Biotechnology Holdings, Inc.	3.40
BCYC	B	Bicycle Therapeutics plc	-4.25
XLO	C	Xilio Therapeutics, Inc.	-10.16
EQ	D	Equillium, Inc.	-6.94
BOLT	F	Bolt Biotherapeutics, Inc.	-2.63
CMPX	F	Compass Therapeutics, Inc.	-1.34
CKPT	F	Checkpoint Therapeutics, Inc.	-8.75
CRVS	F	Corvus Pharmaceuticals, Inc.	-0.71
BCTX	F	BriaCell Therapeutics Corp.	-5.94

Related Industries: Biotechnology

Symbol	Grade	Name	Weight
CNCR	D	Loncar Cancer Immunotherapy ETF	1.27
BBC	D	Virtus LifeSci Biotech Clinical Trials ETF	1.18
INNO	C	Harbor Disruptive Innovation ETF	0.74
IBBQ	D	Invesco Nasdaq Biotechnology ETF	0.09
GWX	C	SPDR S&P International SmallCap ETF	0.09

Compare ETFs

Compare BBC to INNO Compare CNCR to GWX Compare INNO to IBBQ

Date	Stock	Title
Apr 17	CRVS	Here's Why Corvus (CRVS) is Poised for a Turnaround After Losing -25% in 4 Weeks
Apr 16	XLO	Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
Apr 16	CMPX	Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors

Immune Checkpoint: Immune checkpoint inhibitors are a type of cancer treatment that works by blocking certain proteins made by some types of immune system cells. These proteins, known as checkpoints, help keep the immune system from attacking normal cells in the body. By blocking these checkpoints, the immune system is able to recognize and attack cancer cells. Immune checkpoint inhibitors are used to treat a variety of cancers, including melanoma, lung cancer, bladder cancer, and kidney cancer.